BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9010708)

  • 1. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zopiclone.
    Jalava KM; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1996; 51(3-4):331-4. PubMed ID: 9010708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CYP2C8 inhibitor gemfibrozil does not increase the plasma concentrations of zopiclone.
    Tornio A; Neuvonen PJ; Backman JT
    Eur J Clin Pharmacol; 2006 Aug; 62(8):645-51. PubMed ID: 16832679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of erythromycin on the pharmacokinetics and pharmacodynamics of zopiclone.
    Aranko K; Luurila H; Backman JT; Neuvonen PJ; Olkkola KT
    Br J Clin Pharmacol; 1994 Oct; 38(4):363-7. PubMed ID: 7833227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of a single oral dose of brotizolam.
    Osanai T; Ohkubo T; Yasui N; Kondo T; Kaneko S
    Br J Clin Pharmacol; 2004 Nov; 58(5):476-81. PubMed ID: 15521894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.
    Neuvonen PJ; Kantola T; Kivistö KT
    Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma buspirone concentrations are greatly increased by erythromycin and itraconazole.
    Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Sep; 62(3):348-54. PubMed ID: 9333111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem.
    Luurila H; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Apr; 54(2):163-6. PubMed ID: 9626922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concentrations and effects of zopiclone are greatly reduced by rifampicin.
    Villikka K; Kivistö KT; Lamberg TS; Kantola T; Neuvonen PJ
    Br J Clin Pharmacol; 1997 May; 43(5):471-4. PubMed ID: 9159561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CYP 3A4 inhibitor itraconazole has no effect on the pharmacokinetics of i.v. fentanyl.
    Palkama VJ; Neuvonen PJ; Olkkola KT
    Br J Anaesth; 1998 Oct; 81(4):598-600. PubMed ID: 9924238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of itraconazole and CYP2D6*10 genetic polymorphism on the pharmacokinetics and pharmacodynamics of haloperidol in healthy subjects.
    Park JY; Shon JH; Kim KA; Jung HJ; Shim JC; Yoon YR; Cha IJ; Shin JG
    J Clin Psychopharmacol; 2006 Apr; 26(2):135-42. PubMed ID: 16633141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of itraconazole on the pharmacokinetics and pharmacodynamics of bromazepam in healthy volunteers.
    Oda M; Kotegawa T; Tsutsumi K; Ohtani Y; Kuwatani K; Nakano S
    Eur J Clin Pharmacol; 2003 Nov; 59(8-9):615-9. PubMed ID: 14517708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174.
    Kaukonen KM; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.
    Kivistö KT; Kantola T; Neuvonen PJ
    Br J Clin Pharmacol; 1998 Jul; 46(1):49-53. PubMed ID: 9690949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of ingestion time interval on the interaction between itraconazole and triazolam.
    Neuvonen PJ; Varhe A; Olkkola KT
    Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The area under the plasma concentration-time curve for oral midazolam is 400-fold larger during treatment with itraconazole than with rifampicin.
    Backman JT; Kivistö KT; Olkkola KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Mar; 54(1):53-8. PubMed ID: 9591931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the metabolism of etizolam by itraconazole in humans: evidence for the involvement of CYP3A4 in etizolam metabolism.
    Araki K; Yasui-Furukori N; Fukasawa T; Aoshima T; Suzuki A; Inoue Y; Tateishi T; Otani K
    Eur J Clin Pharmacol; 2004 Aug; 60(6):427-30. PubMed ID: 15232663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole.
    Varis T; Kaukonen KM; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 1998 Oct; 64(4):363-8. PubMed ID: 9797792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the systemic antimycotics, itraconazole and fluconazole, on the pharmacokinetics and pharmacodynamics of intravenous and oral midazolam.
    Olkkola KT; Ahonen J; Neuvonen PJ
    Anesth Analg; 1996 Mar; 82(3):511-6. PubMed ID: 8623953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid.
    Neuvonen PJ; Jalava KM
    Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selegiline pharmacokinetics are unaffected by the CYP3A4 inhibitor itraconazole.
    Kivistö KT; Wang JS; Backman JT; Nyman L; Taavitsainen P; Anttila M; Neuvonen PJ
    Eur J Clin Pharmacol; 2001 Apr; 57(1):37-42. PubMed ID: 11372588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.